GADOXETATE for Hepatocellular carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where GADOXETATE was used for Hepatocellular carcinoma.
Most Reported Side Effects for GADOXETATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 173 | 39.8% | 1 | 4 |
| Pain | 162 | 37.2% | 0 | 2 |
| Rash | 162 | 37.2% | 1 | 4 |
| Asthenia | 161 | 37.0% | 1 | 6 |
| Confusional state | 158 | 36.3% | 1 | 6 |
| Burning sensation | 157 | 36.1% | 0 | 3 |
| Hypoaesthesia | 157 | 36.1% | 0 | 2 |
| Arthralgia | 156 | 35.9% | 0 | 1 |
| Paraesthesia | 156 | 35.9% | 0 | 2 |
| Injury | 155 | 35.6% | 0 | 1 |
| Muscle spasms | 155 | 35.6% | 0 | 1 |
| Gadolinium deposition disease | 153 | 35.2% | 0 | 0 |
| Inflammation | 153 | 35.2% | 0 | 0 |
| Mass | 148 | 34.0% | 0 | 0 |
| Anxiety | 93 | 21.4% | 0 | 0 |
Other Indications for GADOXETATE
Nuclear magnetic resonance imaging (111)
Angiogram (76)
Diagnostic procedure (76)
Computerised tomogram (73)
Magnetic resonance imaging (34)
Nuclear magnetic resonance imaging liver (28)
Product used for unknown indication (23)
Magnetic resonance imaging abdominal (15)
Magnetic resonance imaging hepatobiliary (13)
Hepatic lesion (11)
Other Drugs Used for Hepatocellular carcinoma
ATEZOLIZUMAB (8,443)
BEVACIZUMAB (7,773)
LENVATINIB (5,384)
SORAFENIB (4,986)
CABOZANTINIB S-MALATE (2,670)
DURVALUMAB (1,255)
NIVOLUMAB (1,142)
REGORAFENIB (1,050)
TREMELIMUMAB\TREMELIMUMAB-ACTL (589)
PEMBROLIZUMAB (518)